New study finds COVID-19 booster increases antibodies by more than 85% in nursing home residents and their caregivers

The study found that Omicron-specific antibodies reached detectable levels in 86% of nursing home residents and 93% of healthcare workers after receiving the booster shot, compared to just 28% of nursing home residents and healthcare workers after the initial two-dose COVID-19 vaccine series.

COVID-19 vaccine incentives get mixed reception from young people

Offering teens and young adults a chance at a college scholarship, cash, discounts or just some free food might help move the needle on COVID-19 vaccination rates, a new study suggests. In all, 82% of people between the ages of 14 and 24 have a positive attitude toward prizes, raffles, giveaways, and other incentives designed to increase vaccination. But a sizable minority of young people have their doubts about whether such vaccine incentives will work or are ethical.

Comparing SARS-CoV-2 antibody response after Moderna, Pfizer-BioNTech vaccines in immunosuppressed patients

About The Study: Researchers compared antispike antibody titers after the 2-dose Pfizer-BioNTech and Moderna COVID-19 vaccines in incrementally immunosuppressed patients. These individuals, such as people with rheumatic and musculoskeletal diseases and solid organ transplant recipients, have decreased immune responses to these…

Rutgers Expert Available to Discuss Mixing and Matching of COVID-19 Vaccines, Booster Shots

Rutgers infectious disease expert Shobha Swaminathan is available to discuss the mixing and matching of COVID-19 vaccines and boosters as the Food and Drugs Administration authorized booster shots for both the Johnson & Johnson and Moderna vaccines. “There is mounting…

In pregnant women with COVID-19, sex of fetus may influence maternal and placental immune response and neonatal immune protection

In pregnant women who tested positive for SARS-CoV-2, the virus that causes COVID-19, male placentas demonstrated significantly higher levels of certain genes and proteins associated with increased immune activation compared with female placentas, according to a new study published in Science Translational Medicine.

Rutgers Chancellor Available to Discuss COVID-19 Booster Shots, Why Frontline Workers Need Them

Brian L. Strom, chancellor at the Rutgers Biomedical and Health Sciences and executive vice president for Rutgers Health Affairs, is available to discuss the COVID-19 booster shot and why frontline workers need to get them. Strom agrees with the Centers…

Rutgers Global Health Expert Available to Discuss the Global Need for More COVID-19 Vaccines

Rutgers global health expert Richard Marlink, M.D., is available to discuss the importance of prioritizing vaccinations in low- to middle-income countries that need it the most, following President Biden’s pledge to donate an additional 500 million doses of the Pfizer-BioNTech COVID-19…

10 questions you want answered on COVID-19

Should children under the age of 12 be vaccinated against COVID-19? Is it possible to achieve herd immunity? Will an 80 per cent vaccination rate keep us safe? In this video, UniSA epidemiologist Professor Adrian Esterman answers these questions and a lot more. The former World Health Organization consultant shares his expertise – 50 years’ worth – and argues for a different approach to tackling COVID-19.
https://www.youtube.com/watch?v=MLKC9q9yEto

“Automated Vaccine Filling Machine”, An Innovation from Chulalongkorn University, Helps Boost the Number of Vaccinations by 20 Percent, and Reduce the Workload of Medical Personnel

The Faculty of Engineering, Chulalongkorn University has developed an automated vaccine filling machine that can fill AstraZeneca vaccine into syringes with precision, speed, and safety, helping to increase the number of vaccinated people by 20 percent. The prototype is now operating at Chula Vaccination Center and more machines are planned to be built to support frontline medical personnel in many vaccination centers soon.

What you need to know about the delta variant

For more than 40 years, UCI infectious disease researcher Michael Buchmeier has studied coronaviruses, and he’s one of the leading experts on SARS-CoV-2, the version of the virus causing the COVID-19 pandemic. As a more lethal mutation of the virus, called the delta variant, sparks another wave of cases, he offers his expertise about this threat.

Vaccine Hesitancy and Pregnancy: @UCSDHealth expert on why you should get the COVID-19 shot

With recent statewide vaccination mandates, members of the public may have questions or concerns about the safety and effectiveness of COVID-19 vaccination, especially in pregnant mothers. Cynthia Gyamfi-Bannerman, MD, professor and chair of Obstetrics, Gynecology and Reproductive Sciences at UC…

Immune Responses After COVID-19 Vaccination in Kidney Transplant Recipients and Patients on Dialysis

• A large majority of patients with kidney failure on dialysis—but not kidney transplant recipients—developed antibody responses to SARS-CoV-2 after COVID-19 vaccination.
• Vaccination also led to strong T cell responses against the virus that causes COVID-19 in all patients on dialysis, and in nearly 58% of kidney transplant recipients.